Fund Details
LifeSpan Vision Ventures
Overview
Investment portfolio
11rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Remedium Bio | Aug 2026Led | $10 MSeries A | |
Violet Therapeutics | May 2026Led | $5 MSeed | |
Sift Biosciences | Feb 2026Led | $4 MSeed | |
TECregen | Jan 2026Participated | $13 MSeed | |
Immunis | Jan 2025Participated | $25 MSeries A | |
EpiBone | Nov 2024Participated | $1 MOther Equity | |
Integrated Biosciences | Oct 2024Participated | $17 MSeed | |
Matter Bio | May 2024Led | $7 MSeed | |
Senisca | Mar 2024Participated | $5 MSeed | |
Bolden Therapeutics | Jan 2024Participated | $2 MSeed | |
Akadeum Life Sciences | Oct 2021Participated | $18 MSeries B | |
Remedium Bio | Aug 2026Led | $10 MSeries A | |
Violet Therapeutics | May 2026Led | $5 MSeed | |
Sift Biosciences | Feb 2026Led | $4 MSeed | |
TECregen | Jan 2026Participated | $13 MSeed | |
Immunis | Jan 2025Participated | $25 MSeries A | |
EpiBone | Nov 2024Participated | $1 MOther Equity | |
Integrated Biosciences | Oct 2024Participated | $17 MSeed | |
Matter Bio | May 2024Led | $7 MSeed | |
Senisca | Mar 2024Participated | $5 MSeed | |
Bolden Therapeutics | Jan 2024Participated | $2 MSeed | |
Akadeum Life Sciences | Oct 2021Participated | $18 MSeries B |
11 Items
11
Items
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 3 | 4 |
| Series A | 1 | 1 |
| Series B | 0 | 1 |
| Other Equity | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Oct '21 | 1 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 1 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 1 |
| Nov '24 | 1 |
| Dec '24 | 0 |
| Jan '25 | 1 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 1 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 1 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 11 |
| Manufacturing | 1 |
| AI & Machine Learning | 1 |
| AR/VR | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 5 |
| $5M-$10M | 1 |
| $10M-$25M | 4 |
| $25M-$50M | 1 |
| $50M-$100M | 0 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 9 |
| Europe | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Agilent Technologies | 1 |
| APEX Ventures | 1 |
| Arboretum Ventures | 1 |
| Beringea | 1 |
| Berkeley Catalyst Fund | 1 |
| BlueStone Venture Partners | 1 |
| Boehringer Ingelheim | 1 |
| Bold Capital Partners | 1 |
| Carma Fund | 1 |
| Civilization Ventures | 1 |
| Conscience VC | 1 |
| Continuum Health Ventures | 1 |
| Dementia Discovery Fund | 1 |
| Eisai Innovation | 1 |
| Eli Lilly and Company | 1 |
| Emerging Longevity Ventures | 1 |
| EMV Capital | 1 |
| Eos Bioinnovation | 1 |
| Freeflow Ventures | 1 |
| High-Tech Grunderfonds | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 4 | 36% |
| Participating | 7 | 64% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 3 | 75% |
| Co-led | 1 | 25% |